Fig. 4

Outcomes of r/r aggressive B-cell lymphoma cases with concurrent TP53 alterations after CAR19/22 T-cell infusion alone or combined with ASCT. a Best responses after CAR19/22 T-cell infusion alone or combined with ASCT. Kaplan-Meier analysis of DOR (b), PFS (c), and OS (d) is shown